Published in: European Journal of Neuroscience (2002), vol. 16, pp. 2324-2332
Status: Postprint (Author’s version)
locally through a miniperfusion system.
RhoA and Cdc42 GTPase activity assay
Assays for GTPase were performed using five 60 mm culture dishes for each experimental condition (see details
in the Results). The cells were lysed in buffer A (25 mM HEPES pH 7.3, 150 mM NaCl, 5 mM MgCl2, 0.5 mM
EGTA, 0.5% Triton X-100, 4% glycerol, 20 mM β-glycerophosphate, 10 mM NaF, 2 mM Na-orthovanadate, 5
mM dithiothreitol and protease inhibitors) for 10 min at 4 °C; the Triton X-100 insoluble material was removed
by centrifugation (10 min; 9000 g), and the lysates were incubated for 30 min at 4 °C with 20 µg bacterially
produced GST-RBD (glutathione-S-transferase-RhoA binding domain from Rhotekin; Ren et al., 1999) or GST-
CRIB (Cdc42/Rac interactive binding domain from PAK; Bagrodia et al., 1995), which were bound to
glutathione-coupled Sepharose beads. Beads were washed four times in buffer A, resuspended in Laemmli
buffer, and proteins were separated by SDS-PAGE on 12% acrylamide gels. RhoA and Cdc42 were detected by
Western blotting using specific antibodies (RhoA 26C4: sc-418, Santa Cruz Biotechnology; monoclonal anti-
cdc42, BD Biosciences). Before incubation with the beads, 50 µL aliquots were removed from each sample for
determination of total GTPase content. The latter was used to quantify GTPase activation by densitometric
analysis. The optical density of each band on any given Western blot was analysed with PCBAS software
(Raytest, Straubenhardt, Germany). After background subtraction, the ratio of activated/total GTPase was then
calculated and normalized to the lowest ratio value found in the blot.
Cell transfection and immunofluorescence
For immunofluorescence experiments, pituicytes were plated on 18 mm-diameter glass coverslips placed in 35
mm culture dishes. Using the calcium phosphate precipitation method, pituicytes were transfected with a Myc-
tagged pcDNA3 plasmid expressing the Cdc42 GTPase binding domain (GBD) of NWASP, a Wiscott-Aldrich
syndrome protein (WASP)-related protein (material provided by A. Hall, University College, London, UK, and
P. Roux, CNRS UPR 1086, Montpellier, France). After sequential exposure to adenosine and AVP, cells were
fixed with 3% paraformaldehyde + 2% sucrose at 37 °C for 15 min, washed 3 times in PBS, permeabilized for 5
min in PBS + 0.2% Triton, rinsed three times in PBS, and saturated 15 min with 3% bovine serum albumin.
Cells were then incubated overnight at 4 °C with polyclonal anti-Myc antibody (MBL, Nagoya, Japan; diluted 1 :
1000) in order to distinguish transfected from nontransfected cells. After three more rinses in PBS, antirabbit,
FITC-coupled secondary antibody diluted 1 : 100 was applied for 1 h at room temperature. Actin filaments were
labelled simultaneously with Rhodamin-coupled phalloidin (Sigma; 67 ng/mL). After rinsing in phosphate-
buffered saline, coverslips were mounted on slides in the presence of Citifluor for observation on an
epifluorescence microscope.
Drugs
Adenosine, AVP, OXT, bradykinin and BAPTA-AM were purchased from Sigma; the following compounds
were given to us by the indicated persons: SR 49059 ((2S) 1-[(2R 3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-
dimethoxybenzene-sulphonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl]-pyrrolidine-2-carboxamide) and
SR 121463 (1-[4-(N-tert-butylcarbamoyl)-2-methoxybenzene sulphonyl]-5-ethoxy-3-spiro-[4-(2-
morpholinoethoxy)cyclohexane]indoline-2-one) from C. Serradeil-Le Gal (Sanofi-Synthélabo, Toulouse,
France); CL 12-27 ([1-deamino-4-cyclohexylalanine] arginine vasopressin) and d(CH2)5[Tyr(Me)2,Thr4,Tyr-
NH2
9]OVT (dOT) from M. Manning (Medical College of Ohio, Toledo, USA); Y-27632 ((+)-(R)-trans-4-(1-
aminoefhyl)-N-(4-pyridyl)cyclohexane-carboxamide) from A. Yoshimura (Yoshitomi Pharmaceutical Industries,
Osaka, Japan); C3 toxin from P. Boquet (INSERM U-452, Nice, France). None of the solvents at the
maximal concentrations used had any effect on pituicytes (≤ 5% stellation).
Results
AVP and OXT-mediated reversal of adenosine-induced pituicyte stellation
Consistent with our previous work, adenosine induced marked stellation in a vast majority of pituicytes, with a
maximal effect after 30-70 min of treatment (Fig. 1A and B). In the continued presence of agonist, cells
spontaneously reverted to their basal fusiform morphology within approximately 2 h, perhaps as a result of
agonist catabolism or receptor desensitization. However, when we added AVP or OXT 50 min after adenosine,
i.e. around the peak of its effect, reversal of stellation was achieved within about 20 min (Fig. 1C and D). We
then investigated the concentration dependence of AVP- and OXT-induced reversal of stellation. The data
summarized in the graph of Fig. 2 reveal an 'IC50' of 0.1 nM for AVP and 36 nM for OXT. These values are